File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Interim safety, tolerability pharmacokinetics, and antiviral activity of ABI-H0731, a novel core protein allosteric modulator, in healthy volunteers and non-cirrhotic viremic subjects with chronic hepatitis B

TitleInterim safety, tolerability pharmacokinetics, and antiviral activity of ABI-H0731, a novel core protein allosteric modulator, in healthy volunteers and non-cirrhotic viremic subjects with chronic hepatitis B
Authors
Yuen, RMFAgarwal, KGane, ESchwabe, CCheng, WSievert, WKim, DJAhn, SHLim, YSVisvanathan, KRuby, ELiaw, SColonno, RLopatin, U
Issue Date2018
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
Citation
The International Liver Congress 2018 (ILC 2018), Paris, France, 11–15 April 2018. Abstract Book in Journal of Hepatology, 2018, v. 68 n. Suppl. 1, p. S111 How to Cite?
DOI: http://dx.doi.org/10.1016/S0168-8278(18)30439-2
DescriptionPoster Presentation - nio. LBP-012
The Congress was hosted by The European Association for the Study of the Liver (EASL)
Persistent Identifierhttp://hdl.handle.net/10722/263577
ISSN
0168-8278
2023 Impact Factor: 26.8
2023 SCImago Journal Rankings: 9.857
ISI Accession Number ID
WOS:000461068600222

 

DC FieldValueLanguage
dc.contributor.authorYuen, RMF-
dc.contributor.authorAgarwal, K-
dc.contributor.authorGane, E-
dc.contributor.authorSchwabe, C-
dc.contributor.authorCheng, W-
dc.contributor.authorSievert, W-
dc.contributor.authorKim, DJ-
dc.contributor.authorAhn, SH-
dc.contributor.authorLim, YS-
dc.contributor.authorVisvanathan, K-
dc.contributor.authorRuby, E-
dc.contributor.authorLiaw, S-
dc.contributor.authorColonno, R-
dc.contributor.authorLopatin, U-
dc.date.accessioned2018-10-22T07:41:11Z-
dc.date.available2018-10-22T07:41:11Z-
dc.date.issued2018-
dc.identifier.citationThe International Liver Congress 2018 (ILC 2018), Paris, France, 11–15 April 2018. Abstract Book in Journal of Hepatology, 2018, v. 68 n. Suppl. 1, p. S111-
dc.identifier.issn0168-8278-
dc.identifier.urihttp://hdl.handle.net/10722/263577-
dc.descriptionPoster Presentation - nio. LBP-012-
dc.descriptionThe Congress was hosted by The European Association for the Study of the Liver (EASL)-
dc.languageeng-
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep-
dc.relation.ispartofJournal of Hepatology-
dc.relation.ispartofInternational Liver Congress (ILC), 2018-
dc.titleInterim safety, tolerability pharmacokinetics, and antiviral activity of ABI-H0731, a novel core protein allosteric modulator, in healthy volunteers and non-cirrhotic viremic subjects with chronic hepatitis B-
dc.typeConference_Paper-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityYuen, RMF=rp00479-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/S0168-8278(18)30439-2-
dc.identifier.hkuros293846-
dc.identifier.volume68-
dc.identifier.issueSuppl. 1-
dc.identifier.spageS111-
dc.identifier.epageS111-
dc.identifier.isiWOS:000461068600222-
dc.publisher.placeNetherlands-
dc.identifier.issnl0168-8278-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats